Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2000
05/17/2000EP1000621A2 Use of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz (CD) indoles for treating motion sickness and vomiting
05/17/2000EP1000614A1 Sucralfate-containing composition and process for the preparation thereof
05/17/2000EP1000067A1 Thiazolobenzoheterocycles, preparation and medicines containing same
05/17/2000EP1000056A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
05/17/2000EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
05/17/2000EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
05/17/2000EP1000035A1 Substituted 6-phenylphenanthridines
05/17/2000EP1000034A1 Substituted 6-alkylphenanthridines
05/17/2000EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
05/17/2000EP1000028A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
05/17/2000EP1000017A1 Il-8 receptor antagonists
05/17/2000EP0999847A1 Health supplement
05/17/2000EP0999842A1 Novel substituted imidazole compounds
05/17/2000EP0731706B1 Use of dimeticone for the manufacture of a medicament for treating aphthae and stomatitis
05/17/2000EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
05/17/2000CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction
05/17/2000CN1253560A Sulfonamides for treatment of endothelin-mediated disorders
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253558A Substituted imidazoles useful in treatment of inflammatory diseases
05/17/2000CN1253553A Substituted phenyl derivatives, their preparation and use
05/17/2000CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
05/17/2000CN1253505A Pourable alginate compositions
05/17/2000CN1253504A Cytokine related treatments of disease
05/17/2000CN1253501A IL-8 receptor antagonists
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1253017A Medicine for treating appendicitis
05/17/2000CN1253016A Medicinal mixture for treating infantile diarrhea and its preparing process
05/17/2000CN1253013A Medicine for treating hepatism and its preparing process
05/17/2000CN1253000A Exterior-applied medicine 'Yiganzhuanyin liquid' for transforming surface antigen of hepatitis B from positive to negative
05/17/2000CN1052416C Medicine bag for treatment of indigestion and child digestive disorder and its preparing process
05/17/2000CN1052413C Yinhuang Ganfu powder for curing hepatitis and its preparing process
05/16/2000US6063935 Cultivating a bacteria of a bacillus genus capable of producing 3,3-dihydroxyazetidine or salt thereof to produce the 3,3-dihydroxyazetidine or salt in culture medium and collecting the product
05/16/2000US6063903 Ligands for EPH-like receptors
05/16/2000US6063810 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
05/16/2000US6063802 Ondansetron freeze-dried dosage form compositions for oral administration
05/16/2000US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor
05/16/2000US6063796 Heterocyclic compounds of piperidine
05/16/2000US6063784 Heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them
05/16/2000US6063782 Pyrrolopyridazine derivatives
05/16/2000US6063400 Targeted liposomal constructs for diagnostic and therapeutic uses
05/16/2000CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists
05/16/2000CA2180263C Diazabicyclic neurokinin antagonists
05/11/2000WO2000026380A1 Rotavirus subunit vaccine
05/11/2000WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/11/2000WO2000026252A1 Compounds with growth hormone releasing properties
05/11/2000WO2000026245A2 Human membrane transport proteins
05/11/2000WO2000026243A2 Transmembrane 4 proteins
05/11/2000WO2000026224A2 Novel macrolide antibiotics
05/11/2000WO2000026217A1 Imidazonaphthyridines
05/11/2000WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026205A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
05/11/2000WO2000026201A1 Benzoylpyridazines
05/11/2000WO2000025797A1 Combination therapy to treat hepatitis b virus
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025788A1 Inhibitors of prenyl-protein transferase
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025742A1 Expandable gastroretentive therapeutical system with prolonged stomach retention time
05/11/2000WO2000008007A3 Cyclopentabenzofuran derivatives and their use
05/11/2000WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/11/2000WO1999060984A3 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
05/11/2000DE19851184A1 N-Arylsulfonyl-aminosäure-omega-amide N-arylsulfonyl-amino-omega-amides
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000CA2349476A1 Imidazonaphthyridines
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2348777A1 Rotavirus subunit vaccine
05/11/2000CA2348703A1 Inhibitors of prenyl-protein transferase
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0999205A1 Aminocycloalkane compounds
05/10/2000EP0998585A1 SCREENING METHODS USING AN ATPASE PROTEIN FROM A VIRUS OF THE $i(FLAVIVIRIDAE) FAMILY
05/10/2000EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998454A2 Metalloproteinase inhibitors
05/10/2000EP0998295A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients
05/10/2000EP0998293A1 Cytokine related treatments of disease
05/10/2000EP0998292A2 Method for inhibiting bone resorption
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000EP0998252A1 Dental resin cements having improved handling properties
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000EP0602172B1 A method for treatment of patients with chronic liver disease
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252798A Indazole amide compounds as 5-serotoninergic agents
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252722A Use of descarboethoxyloratadine for manfacture of medicament for treatment of urinary incontinence, motion sickness and vertigo
05/10/2000CN1252721A Pharmaceutical composition
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252305A Sucking-dog oral liquid and its compounding process
05/10/2000CN1252287A Hepatosis treating medicine and its preparation
1 ... 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 ... 1258